Mettler-Toledo International Inc.
NYSE-MTD
Company Overview
Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection, x-ray, checkweighing, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of networked scales and software, stand-alone scales, and automated packaging and labeling solutions for handling fresh goods. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. The company was incorporated in 1991 and is based in Columbus, Ohio.
Name
Mettler-Toledo International Inc.
CEO
Mr. Patrick K. Kaltenbach
Website
www.mt.com
Sector
Life Sciences Tools and Services
Year Founded
1991
Profile
Market Cap
$30.62B
EV
$32.61B
Shares Out
21.22M
Revenue
$3,750.15M
Employees
16,000
Margins
Gross
59.33%
EBITDA
30.44%
Operating
28.38%
Pre-Tax
25.26%
Net
20.95%
FCF
23.96%
Returns (5Yr Avg)
ROA
23.64%
ROTA
1,272.92%
ROE
170.65%
ROCE
45.09%
ROIC
32.22%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$1,382
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$70.81M
Net Debt
$1,987.07M
Debt/Equity
-13.47
EBIT/Interest
13.62
Growth (CAGR)
Rev 3Yr
2.58%
Rev 5Yr
4.82%
Rev 10Yr
4.41%
Dil EPS 3Yr
6.75%
Dil EPS 5Yr
11.04%
Dil EPS 10Yr
13.25%
Rev Fwd 2Yr
2.66%
EBITDA Fwd 2Yr
4.53%
EPS Fwd 2Yr
7.95%
EPS LT Growth Est
11.03%
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—